Publicaciones en las que colabora con ESTHER MARIA BERROCOSO DOMINGUEZ (25)

2024

  1. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  2. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

2023

  1. Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis

    Journal of Neuroinflammation, Vol. 20, Núm. 1

2022

  1. The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia

    Frontiers in Pharmacology, Vol. 13

2021

  1. A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748

  2. Automated mouse pupil size measurement system to assess locus coeruleus activity with a deep learning-based approach

    Sensors, Vol. 21, Núm. 21

  3. Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C

    European Neuropsychopharmacology, Vol. 46, pp. 14-27

  4. P.0150 Therapeutic and preventive efficacy of mangiferin in an experimental model of schizophrenia

    34th ECNP Congress – Lisbon 2021 Hybrid

  5. P.0252 N-acetylcysteine supplement during pregnancy may prevent some of the behavioral and neuroanatomical deficits in a schizophrenia-like rat model

    European Neuropsychopharmacology, Vol. 53, pp. S183-S184

  6. P.0886 Cannabinoids in the prevention of behavioral and brain deficits in a schizophrenia-like rat model

    European Neuropsychopharmacology, Vol. 53, pp. S649-S650

2019

  1. Deep brain stimulation: Mechanisms underpinning antidepressant effects

    Neurobiology of Depression: Road to Novel Therapeutics (Elsevier), pp. 375-382

  2. Monoaminergic system and depression

    Cell and Tissue Research, Vol. 377, Núm. 1, pp. 107-113

  3. Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model

    European Neuropsychopharmacology, Vol. 29, Núm. 7, pp. 880-896

2018

  1. Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats

    Brain Stimulation, Vol. 11, Núm. 1, pp. 222-230

  2. Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain

    Neuropharmacology, Vol. 135, pp. 202-210

2017

  1. Cellular and molecular mechanisms triggered by Deep Brain Stimulation in depression: A preclinical and clinical approach

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 73, pp. 1-10

  2. Deep brain stimulation: A promising therapeutic approach to the treatment of severe depressed patients - current evidence and intrinsic mechanisms

    Psychiatry and Neuroscience Update (Springer International Publishing), pp. 251-264

  3. Formación específica para la correcta realización de una comunicaciónoral dirigido a estudiantes de Grado

    II Jornadas de Innovación Docente Universitaria UCA

2014

  1. Fluoxetine: A case history of its discovery and preclinical development

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 5, pp. 567-578

  2. Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats

    European Neuropsychopharmacology, Vol. 24, Núm. 6, pp. 996-1003